|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's range||17.01 - 18.06|
|52-week range||7.39 - 28.40|
|Beta (5Y monthly)||0.89|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Hutchison China MediTech (HCM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
While the world wrestles with the impact of Covid, inflation and geopolitical strife, investors are naturally wondering what lies in store for some of the coun...
Geopolitical and economic turmoil has changed the outlook for companies across all industry sectors. For investors who own shares in them, the question now is...